The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model

Introduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debat...

Full description

Saved in:
Bibliographic Details
Main Authors: Denisa Miklankova, Irena Markova, Martina Hüttl, Barbora Stankova, Hana Malinska
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2022/4587907
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554750021730304
author Denisa Miklankova
Irena Markova
Martina Hüttl
Barbora Stankova
Hana Malinska
author_facet Denisa Miklankova
Irena Markova
Martina Hüttl
Barbora Stankova
Hana Malinska
author_sort Denisa Miklankova
collection DOAJ
description Introduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results. Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions. Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.
format Article
id doaj-art-26e94ca82d9c4cec87d8e861d37f6ebe
institution Kabale University
issn 2314-6753
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-26e94ca82d9c4cec87d8e861d37f6ebe2025-02-03T05:50:36ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/4587907The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes ModelDenisa Miklankova0Irena Markova1Martina Hüttl2Barbora Stankova3Hana Malinska4Centre for Experimental MedicineCentre for Experimental MedicineCentre for Experimental MedicineFirst Faculty of MedicineCentre for Experimental MedicineIntroduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results. Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions. Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.http://dx.doi.org/10.1155/2022/4587907
spellingShingle Denisa Miklankova
Irena Markova
Martina Hüttl
Barbora Stankova
Hana Malinska
The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
Journal of Diabetes Research
title The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
title_full The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
title_fullStr The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
title_full_unstemmed The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
title_short The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
title_sort different insulin sensitising and anti inflammatory effects of palmitoleic acid and oleic acid in a prediabetes model
url http://dx.doi.org/10.1155/2022/4587907
work_keys_str_mv AT denisamiklankova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT irenamarkova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT martinahuttl thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT barborastankova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT hanamalinska thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT denisamiklankova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT irenamarkova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT martinahuttl differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT barborastankova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel
AT hanamalinska differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel